Trial Profile
Phase II study of 6 weeks intravesical gemcitabine instillation followed by transurethral resection in patients affected by superficial bladder cancer at low risk
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2006
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 28 Jul 2006 Status change
- 05 Nov 2005 New trial record.